{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:10:32Z","timestamp":1775567432980,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-05907-z","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:33:50Z","timestamp":1772282030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monotherapy versus combination therapy in severe Legionella pneumonia: a multicenter retrospective observational study"],"prefix":"10.1186","volume":"30","author":[{"given":"Manon","family":"Bouteiller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Coss\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtan","family":"Beduneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Giry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Barrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolan","family":"Malherbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Vodovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Tamion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"5907_CR1","unstructured":"Camp\u00e8se C, Descours G, Bernard-Stoecklin S, Beraud L, Maine C, Ranc AG et al. La l\u00e9gionellose en France: importante augmentation du nombre de cas en 2018. Bull Epid\u00e9miol Hebd. 2019;(4):89\u201395."},{"key":"5907_CR2","unstructured":"ECDC. (2019). Legionnaires\u2019 Disease\u2014Annual Epidemiological Report for 2015."},{"key":"5907_CR3","volume-title":"Legionnaires\u2019 disease surveillance summary report","author":"PP Shah","year":"2018","unstructured":"Shah PP, Barskey AE, Binder AM, Edens C, Lee S, Smith JC, Cooley LA. Legionnaires\u2019 disease surveillance summary report. United States: 2014\u2009\u2013\u20091015; 2018."},{"issue":"10","key":"5907_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1469-0691.2005.01226.x","volume":"11","author":"F Gutierrez","year":"2005","unstructured":"Gutierrez F, Masia M, Rodriguez JC, Mirete C, Sold\u00e1n B, Padilla S, Hidalgo AM. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect. 2005;11(10):788\u2013800.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5907_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.idc.2016.10.009","volume":"31","author":"A Chahin","year":"2017","unstructured":"Chahin A, Opal SM. Severe pneumonia caused by Legionella pneumophila: differential diagnosis and therapeutic considerations. Infect Dis Clin North Am. 2017;31(1):111\u201321.","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"5907_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5644\/ama2006-124.7","volume":"40","author":"M Kojicic","year":"2011","unstructured":"Kojicic M, Li G, Gajic O. Acute respiratory distress syndrome in patients with Legionella pneumonia. Acta Med Acad. 2011;40(1):39\u201344.","journal-title":"Acta Med Acad"},{"key":"5907_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/cce.0000000000000508","author":"L Andrea","year":"2021","unstructured":"Andrea L, Dicpinigaitis PV, Fazzari MJ, Kapoor S. Legionella pneumonia in the ICU: a tertiary care center experience over 10 years. Crit Care Explor. 2021. https:\/\/doi.org\/10.1097\/cce.0000000000000508.","journal-title":"Crit Care Explor"},{"issue":"1","key":"5907_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13613-024-01252-y","volume":"14","author":"J Rello","year":"2024","unstructured":"Rello J, Allam C, Ruiz-Spinelli A, Jarraud S. Severe Legionnaires\u2019 disease. Ann Intensive Care. 2024;14(1):51.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"5907_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s15010-020-01565-7","volume":"49","author":"M Falcone","year":"2021","unstructured":"Falcone M, Russo A, Tiseo G, Cesaretti M, Guarracino F, Menichetti F. Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy. Infection. 2021;49(2):321\u20135.","journal-title":"Infection"},{"issue":"6","key":"5907_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00134-002-1304-8","volume":"28","author":"A Gacouin","year":"2002","unstructured":"Gacouin A, Le Tulzo Y, Lavoue S, Camus C, Hoff J, Bassen R, et al. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med. 2002;28(6):686\u201391.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5907_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/MD.0b013e31827f6104","volume":"92","author":"D Viasus","year":"2013","unstructured":"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Carratala J. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2013;92(1):51\u201360.","journal-title":"Medicine"},{"issue":"8","key":"5907_CR12","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1128\/AAC.39.8.1661","volume":"39","author":"AL Baltch","year":"1995","unstructured":"Baltch AL, Smith RP, Ritz W. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. Antimicrob Agents Chemother. 1995;39(8):1661\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"5907_CR13","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1128\/AAC.42.12.3153","volume":"42","author":"AL Baltch","year":"1998","unstructured":"Baltch AL, Smith RP, Franke MA, Michelsen PB. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila. Antimicrob Agents Chemother. 1998;42(12):3153\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"5907_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-022-00635-7","author":"D Viasus","year":"2022","unstructured":"Viasus D, Gaia V, Manzur-Barbur C, Carratal\u00e0 J. Legionnaires\u2019 Disease: update on diagnosis and treatment. Infect Dis Ther. 2022. https:\/\/doi.org\/10.1007\/s40121-022-00635-7.","journal-title":"Infect Dis Ther"},{"issue":"11","key":"5907_CR15","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/cid\/ciaa441","volume":"72","author":"AS Jasper","year":"2021","unstructured":"Jasper AS, Musuuza JS, Tischendorf JS, Stevens VW, Gamage SD, Osman F, Safdar N. Are fluoroquinolones or macrolides better for treating Legionella pneumonia? A systematic review and meta-analysis. Clin Infect Dis. 2021;72(11):1979\u201389.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5907_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jiac.2020.10.002","volume":"27","author":"H Kato","year":"2021","unstructured":"Kato H, Hagihara M, Asai N, Shibata Y, Koizumi Y, Yamagishi Y, Mikamo H. Meta-analysis of fluoroquinolones versus macrolides for treatment of Legionella pneumonia. J Infect Chemother. 2021;27(3):424\u201333.","journal-title":"J Infect Chemother"},{"issue":"Suppl 3","key":"5907_CR17","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","volume":"64","author":"WS Lim","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1\u201355.","journal-title":"Thorax"},{"issue":"9","key":"5907_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.medmal.2012.06.005","volume":"42","author":"N Dumarcet","year":"2012","unstructured":"Dumarcet N. Updates for the antibiotic treatment of legionellosis in adults. M\u00e9d Mal Infect. 2012;42(9):393\u2013413.","journal-title":"M\u00e9d Mal Infect"},{"issue":"7","key":"5907_CR19","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Whitney CG. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"5907_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.rmr.2025.01.003","volume":"42","author":"A Dinh","year":"2025","unstructured":"Dinh A, Barbier F, Bedos JP, Blot M, Cattoir V, Claessens YE, et al. Actualisation des recommandations de prise en charge des pneumonies aigu\u00ebs communautaires chez l\u2019adulte par la Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (SPILF) et la Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise (SPLF). Avec le soutien de la Soci\u00e9t\u00e9 de r\u00e9animation de langue fran\u00e7aise, (SRLF), de la Soci\u00e9t\u00e9 fran\u00e7aise de microbiologie (SFM), de la Soci\u00e9t\u00e9 fran\u00e7aise de radiologie (SFR) et de la Soci\u00e9t\u00e9 fran\u00e7aise de m\u00e9decine d\u2019urgence (SFMU) [Update of guidelines for management of Community Acquired pneumonia in adults by French Infectious Disease Society (SPILF) and the French Speaking Society of Respiratory Diseases (SPLF). Endorsed by French intensive care society (SRLF), French microbiology society (SFM), French radiology society (SFR), French emergency society (SFMU)]. Rev Mal Respir. 2025;42(3):168\u201386. https:\/\/doi.org\/10.1016\/j.rmr.2025.01.003.","journal-title":"Rev Mal Respir"},{"issue":"24","key":"5907_CR21","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270(24):2957\u201363.","journal-title":"JAMA"},{"key":"5907_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Taylor Thompson B, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"issue":"5","key":"5907_CR23","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/jac\/dkx007","volume":"72","author":"J Cecchini","year":"2017","unstructured":"Cecchini J, Tuffet S, Sonneville R, Fartoukh M, Mayaux J, Roux D, et al. Antimicrobial strategy for severe community-acquired legionnaires\u2019 disease: a multicentre retrospective observational study. J Antimicrob Chemother. 2017;72(5):1502\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"5907_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/qjmed\/hct167","volume":"106","author":"JF Irons","year":"2013","unstructured":"Irons JF, Dunn MJG, Kefala K, Thorn S, Lakha F, Caesar D, et al. The effect of a large Legionnaires\u2019 disease outbreak in Southwest Edinburgh on acute and critical care services. QJM Int J Med. 2013;106(12):1087\u201394.","journal-title":"QJM Int J Med"},{"issue":"7","key":"5907_CR25","first-page":"557","volume":"43","author":"CW He","year":"2020","unstructured":"He CW, Tang X, Sun B, Li XY, Wang R, Li Y, et al. Severe community-acquired pneumonia caused by Legionella pneumophila with acute respiratory failure: Clinical characteristics and prognosis of 34 cases. Zhonghua jie he he hu xi za zhi= Zhonghua Jiehe he Huxi Zazhi= Chinese Journal of Tuberculosis and Respiratory Diseases. 2020;43(7):557\u201363.","journal-title":"Zhonghua jie he he hu xi za zhi= Zhonghua Jiehe he Huxi Zazhi= Chinese Journal of Tuberculosis and Respiratory Diseases"},{"issue":"5","key":"5907_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.medin.2012.05.010","volume":"37","author":"J Rello","year":"2013","unstructured":"Rello J, Gattarello S, Souto J, Sole-Violan J, Valles J, Peredo R, et al. Community-acquired Legionella pneumonia in the intensive care unit: impact on survival of combined antibiotic therapy. Med Intensiva. 2013;37(5):320\u20136.","journal-title":"Med Intensiva"},{"issue":"4","key":"5907_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF01695659","volume":"15","author":"CH Heath","year":"1996","unstructured":"Heath CH, Grove DI, Looke DFM. Delay in appropriate therapy ofLegionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis. 1996;15(4):286\u201390.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5907_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1374-9","volume":"16","author":"A Levcovich","year":"2016","unstructured":"Levcovich A, Lazarovitch T, Moran-Gilad J, Peretz C, Yakunin E, Valinsky L, Weinberger M. Complex clinical and microbiological effects on Legionnaires\u2019 disease outcome; A retrospective cohort study. BMC Infect Dis. 2016;16:1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"20","key":"5907_CR29","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366(20):1881\u201390.","journal-title":"N Engl J Med"},{"key":"5907_CR30","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S284171","author":"A Althaqafi","year":"2021","unstructured":"Althaqafi A, Ali M, Alzahrani Y, Ming LC, Hussain Z. How safe are fluoroquinolones for diabetic patients? A systematic review of dysglycemic and neuropathic effects of fluoroquinolones. Ther Clin Risk Manag. 2021. https:\/\/doi.org\/10.2147\/TCRM.S284171.","journal-title":"Ther Clin Risk Manag"},{"key":"5907_CR31","doi-asserted-by":"publisher","unstructured":"Kabbara WK, Ramadan WH, Rahbany P, Al-Natour S. (2015). Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia. Ther Clin Risk Manag, 639\u201347. https:\/\/doi.org\/10.2147\/TCRM.S81280","DOI":"10.2147\/TCRM.S81280"},{"issue":"3","key":"5907_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2024-002925","volume":"13","author":"JG Rizk","year":"2024","unstructured":"Rizk JG, Slejko JF, Heil EL, Seo D, Qato DM. Impact of the US Food and Drug Administration warning regarding increased risk of aortic aneurysms or aortic dissections on fluoroquinolone prescribing trends. BMJ Open Qual. 2024;13(3):e002925.","journal-title":"BMJ Open Qual"},{"issue":"7","key":"5907_CR33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jiac.2015.12.019","volume":"22","author":"K Mikasa","year":"2016","unstructured":"Mikasa K, Aoki N, Aoki Y, Abe S, Iwata S, Ouchi K, et al. JAID\/JSC guidelines for the treatment of respiratory infectious diseases: the Japanese Association for Infectious Diseases\/Japanese Society of Chemotherapy\u2013the JAID\/JSC guide to clinical management of infectious disease\/guideline-preparing committee respiratory infectious disease WG. J Infect Chemother. 2016;22(7):S1\u201365.","journal-title":"J Infect Chemother"},{"issue":"6","key":"5907_CR34","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1128\/AAC.40.6.1419","volume":"40","author":"SJ Martin","year":"1996","unstructured":"Martin SJ, Pendland SL, Chen C, Schreckenberger P, Danziger LH. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella. Antimicrob Agents Chemother. 1996;40(6):1419\u201321.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5907_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0732-8893(97)81806-8","volume":"29","author":"SJ Martin","year":"1997","unstructured":"Martin SJ, Pendland SL, Chen C, Schreckenberger PC, Danziger LH. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. Diagn Microbiol Infect Dis. 1997;29(3):167\u201371.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"5907_CR36","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1128\/AAC.44.8.2176-2178.2000","volume":"44","author":"MT Garc\u00eda","year":"2000","unstructured":"Garc\u00eda MT, Pelaz C, Gim\u00e9nez MJ, Aguilar L. In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results. Antimicrob Agents Chemother. 2000;44(8):2176\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5907_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.7326\/0003-4819-129-4-199808150-00012","volume":"129","author":"PH Edelstein","year":"1998","unstructured":"Edelstein PH. Antimicrobial chemotherapy for Legionnaires disease: time for a change. Ann Intern Med. 1998;129(4):328\u201330.","journal-title":"Ann Intern Med"},{"issue":"9","key":"5907_CR38","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","volume":"43","author":"N V\u00e1zquez-Laslop","year":"2018","unstructured":"V\u00e1zquez-Laslop N, Mankin AS. How macrolide antibiotics work. Trends Biochem Sci. 2018;43(9):668\u201384.","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"5907_CR39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1128\/AAC.01474-10","volume":"55","author":"T Sato","year":"2011","unstructured":"Sato T, Tateda K, Kimura S, Ishii Y, Yamaguchi K. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Antimicrob Agents Chemother. 2011;55(4):1594\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5907_CR40","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12879-024-09353-6","volume":"24","author":"N Takahashi","year":"2024","unstructured":"Takahashi N, Imaeda T, Oami T, Abe T, Shime N, Komiya K, Nakada TA. Incidence and mortality of community-acquired and nosocomial infections in Japan: a nationwide medical claims database study. BMC Infect Dis. 2024;24(1):518.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"5907_CR41","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1128\/AAC.41.10.2256","volume":"41","author":"SC Chien","year":"1997","unstructured":"Chien SC, Rogge MC, Gisclon LG, Curtin C, Wong F, Natarajan J, Chow AT. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrob Agents Chemother. 1997;41(10):2256\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5907_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/cid\/ciad196","volume":"77","author":"A Deshpande","year":"2023","unstructured":"Deshpande A, Klompas M, Guo N, Imrey PB, Pallotta AM, Higgins T, Rothberg MB. Intravenous to oral antibiotic switch therapy among patients hospitalized with community-acquired pneumonia. Clin Infect Dis. 2023;77(2):174\u201385.","journal-title":"Clin Infect Dis"},{"key":"5907_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-2994-1-25","volume":"1","author":"J Carlet","year":"2012","unstructured":"Carlet J, Rambaud C, Pulcini C. WAAR (World Alliance against Antibiotic Resistance): safeguarding antibiotics. Antimicrob Resist Infect Control. 2012;1:1\u20136.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5907_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27984","author":"N Morales-Dur\u00e1n","year":"2024","unstructured":"Morales-Dur\u00e1n N, Le\u00f3n-Buitimea A, Morones-Ram\u00edrez JR. Unraveling resistance mechanisms in combination therapy: a comprehensive review of recent advances and future directions. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27984.","journal-title":"Heliyon"},{"key":"5907_CR45","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-015-3853-7","volume":"41","author":"C Bretonni\u00e8re","year":"2015","unstructured":"Bretonni\u00e8re C, Leone M, Mil\u00e9si C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bedos JP. Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med. 2015;41:1181\u201396.","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-05907-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05907-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05907-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:39:11Z","timestamp":1775565551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-05907-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5907"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-05907-z","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee for non-interventional research of Rouen University Hospital gave approval for this study (N\u00b01058).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}